首頁 › 重度憂鬱症 › 阿肯色 › Little Rock
Little Rock, AR 的 重度憂鬱症 臨床試驗
14 項針對 重度憂鬱症 的研究正在 Little Rock（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
招募中3 期
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 距離 15 英里
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 距離 15 英里
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
招募中4 期
- Neurocrine Clinical Site, Bryant · 距離 15 英里
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
招募中3 期
- SanRo Clinical Research Group, Bryant · 距離 15 英里
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Bryant · 距離 15 英里
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 距離 15 英里
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
招募中2 期
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Little Rock
其他城市的 重度憂鬱症 試驗
- New York City, NY36 項研究
- Boston, MA31 項研究
- Atlanta, GA25 項研究
- Philadelphia, PA23 項研究
- Orlando, FL19 項研究
- Miami, FL18 項研究
- Chicago, IL17 項研究
- Tampa, FL17 項研究
- Houston, TX16 項研究
- San Diego, CA16 項研究
- Austin, TX13 項研究
- Las Vegas, NV13 項研究
Little Rock 的其他研究
- 精神分裂症19 項研究
- 癌症（所有類型）14 項研究
- 急性髓系白血病13 項研究
- 非小細胞肺癌13 項研究
- 肥胖症11 項研究
- 子宮內膜癌10 項研究
- 憂鬱症10 項研究
- 第二型糖尿病10 項研究
- 肺癌9 項研究
- 心血管疾病9 項研究
- 膀胱癌9 項研究
- 心臟衰竭9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。